Page last updated: 2024-08-18

4-butyrolactone and aphidicolin

4-butyrolactone has been researched along with aphidicolin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anger, M; Carnwath, JW; Kues, WA; Motlik, J; Niemann, H; Paul, D1
Hirata, M; Ishizaka, Y; Minemoto, Y; Nakagama, H; Ohtsubo, M; Sasagawa, T; Shimura, M; Uchida, S; Yamashita, K1

Other Studies

2 other study(ies) available for 4-butyrolactone and aphidicolin

ArticleYear
Cell cycle synchronization of porcine fetal fibroblasts: effects of serum deprivation and reversible cell cycle inhibitors.
    Biology of reproduction, 2000, Volume: 62, Issue:2

    Topics: 4-Butyrolactone; Animals; Aphidicolin; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; DNA Fragmentation; Enzyme Inhibitors; Fetus; Fibroblasts; Flow Cytometry; In Situ Nick-End Labeling; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swine; Transcription, Genetic

2000
Loss of p53 induces M-phase retardation following G2 DNA damage checkpoint abrogation.
    Archives of biochemistry and biophysics, 2003, Apr-01, Volume: 412, Issue:1

    Topics: 4-Butyrolactone; Antineoplastic Agents; Aphidicolin; Blotting, Western; Caffeine; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; Flow Cytometry; G2 Phase; Humans; Mitosis; Oncogene Proteins, Viral; Phenotype; Protein Kinases; Protein Serine-Threonine Kinases; Repressor Proteins; S Phase; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2003